Inactive Instrument
Lipidor AB Stock Nasdaq Stockholm
Stocks
LIPI
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -6.52% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.52% | -24.56% | - | - | 92.63K | |
| +0.33% | +4.56% | +48.40% | +163.57% | 1,067B | |
| +1.15% | +7.31% | +60.64% | +53.73% | 635B | |
| -0.70% | +1.76% | +36.77% | +73.22% | 458B | |
| +1.41% | +8.56% | +38.18% | +32.17% | 347B | |
| +1.28% | +4.40% | +37.69% | +41.62% | 295B | |
| +1.72% | +4.10% | +19.44% | +20.45% | 262B | |
| +1.84% | -0.46% | -27.63% | -38.65% | 216B | |
| +0.43% | +3.39% | +24.97% | +59.51% | 203B | |
| +1.42% | -1.49% | +16.10% | +71.52% | 161B | |
| Average | +0.39% | +2.02% | +28.29% | +53.02% | 404.83B | |
| Weighted average by Cap. | +0.91% | +3.41% | +37.91% | +78.54% |
Employees
4
Sector
Pharmaceuticals
